Dr Anne Langsted, University of Copenhagen, Denmark, presents genetic and observational research investigating whether low levels of Lp(a) are associated with increased risk of cancer, infectious diseases, mental disorders, and diabetes.
AstraZeneca has provided a sponsorship grant towards this independent programme.